Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus

Table 2

Correlations between changes in the BMI from baseline to week 52 and cardiometabolic indices after exenatide treatment.

	HbA1c	hsCRP	SBP	LDL-C
Correlation coefficient (r)	0.419	0.440	0.510	−0.270
value	0.030	0.022	0.007	0.173

value was analyzed by the mean change comparison between exenatide and insulin groups. HbA1c: glycated hemoglobin; hsCRP: high sensitivity C-reactive protein; SBP: systolic blood pressure; LDL-C: low-density lipoprotein cholesterol.